Prof. Xiaoyu Yin: Authority in Complex Hepatobiliary-Pancreatic Oncology & Robotic Surgery at FAH-SYSU

Professional Profile

Prof. Xiaoyu Yin is an internationally renowned surgical oncologist, Chief Physician, Professor, Doctoral Supervisor, and Academic Leader of Biliary-Pancreatic Surgery at The First Affiliated Hospital, Sun Yat-sen University (FAH-SYSU). Regarded as one of the definitive authorities in digestive oncology across South China, Prof. Yin has dedicated decades to advancing surgical boundaries in hepatobiliary and pancreatic malignancies.

Widely recognized as a pioneer in robotic surgical innovation, Prof. Yin is celebrated for undertaking high-complexity resections for cases previously considered inoperable. His clinical practice excels in combined vascular resections and reconstructions, radical hilar lymphadenectomies, and multi-modal systemic conversion regimens that downstage locally advanced liver, biliary, and pancreatic tumors to achieve curative-intent clearance.

Key Clinical Specializations

• Massive Hepatocellular Carcinoma (HCC) & Extreme Liver Surgery: Radical anatomical hepatectomies for massive, central, and multi-nodular liver cancers, integrating 3D digital planning, hepatic vein reconstruction, and future liver remnant (FLR) hypertrophy strategies.
• Complex Pancreaticoduodenectomy (Whipple Procedure): Curative resections for pancreatic head adenocarcinoma and periampullary neoplasms, specializing in complex mesenteric-portal vein resection, artificial graft reconstruction, and artery-first dissection techniques.
• Hilar Cholangiocarcinoma (Klatskin Tumors): Ultra-radical biliary tract resections combining extended hemihepatectomy, caudate lobectomy, and skeletonization of the hepatic hilum to achieve R0 surgical margins.
• Pioneering Robotic Hepatobiliary-Pancreatic Surgery: Performing high-precision da Vinci robotic hepatectomies, distal pancreatectomies, and robotic pancreaticoduodenectomies, offering superior anatomical visualization, tremor-free microsuturing, minimal blood loss, and rapid postoperative recovery.
• Multidisciplinary Neoadjuvant Conversion Therapy: Formulating aggressive systemic immunotherapy, anti-angiogenic targeted therapy, and local interventional combinations (HAIC/TACE/Y90) to downstage initially unresectable hepatobiliary-pancreatic tumors into surgical candidates.

Academic Leadership & Landmark Research (2024–2025)

Prof. Xiaoyu Yin has established an extraordinary academic legacy with continuous contributions to top-tier global surgical and hepatology literature, including landmark publications in Hepatology and Annals of Surgery:

• Landmark Publications in Hepatology: Unveiling multi-center clinical trials on neoadjuvant targeted-immunotherapy regimens for advanced hepatocellular carcinoma, establishing predictive molecular biomarkers for successful surgical downstaging and recurrence-free survival.
• High-Impact Findings in Annals of Surgery: Reporting long-term comparative oncological survival, functional recovery, and complication profiles in major cohorts undergoing robotic versus open complex hepatobiliary-pancreatic resections.
• National Consensus Guidelines: Leading the drafting of Chinese expert consensuses on robotic pancreatic surgery, vascular reconstruction in pancreatic cancer, and standard clinical guidelines for biliary tract carcinoma management.

International Patient Coordination & Fast-Track Access

China Medical Concierge – Shanghai (CMCS) provides dedicated health management and medical concierge services connecting domestic and overseas patients with China’s premier surgical masters. For patients seeking evaluation and complex surgical planning with Prof. Xiaoyu Yin at FAH-SYSU, CMCS offers comprehensive support:

• Multidisciplinary expert second opinions on contrast-enhanced CT, MRI-CP, and liver function assessments;
• Fast-track outpatient appointments and expedited inpatient surgical admission coordination at FAH-SYSU;
• Evaluation for robotic surgical feasibility and customized neoadjuvant conversion protocols;
• End-to-end medical translation, bilingual patient accompaniment, and longitudinal postoperative follow-up care.